ALL NEWS TODAY

[ ALL NEWS TODAY ]

Novartis Says Meningitis Vaccine Performed Well in Large Trial - Wall Street Journal


Novartis Says Meningitis Vaccine Performed Well in Large Trial
Wall Street Journal - 2 hours ago
By JEANNE WHALEN Swiss drug maker Novartis AG said Tuesday that its experimental meningitis vaccine performed well in a large clinical trial and that the company expects to file it for regulatory approval in the US and Europe this year.
UPDATE 1-Novartis says Menveo improves meningitis immunity Reuters
Novartis has high hopes for vaccine Boston Globe
USA Today - FOXBusiness - FierceBiotech - Forbes
all 26 news articles
Comments: [0] / Post comment:
02 Dec 2008 15:53:18

Mylan, Novartis settle patent dispute on Femara - CNNMoney.com

Mylan, Novartis settle patent dispute on Femara CNNMoney.com - NEW YORK (Associated Press) - Mylan Inc. said Tuesday it reached a settlement allowing it eventually to market a generic version of Novartis ' breast cancer ... Mylan Announces Settlement Agreement with Novartis Related to ... UPDATE 1- Novartis , Mylan agree on Femara generic Mylan settles with Novartis on Femara generic - Update
02 Dec 2008 15:08:42

BRIEF-Novartis confirms Femara agreement with Mylan - Forbes

BRIEF- Novartis confirms Femara agreement with Mylan Forbes, NY - The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior ...
02 Dec 2008 15:07:53

UPDATE 2-Data supports Novartis malaria drug -US FDA staff - Reuters

Current World News UPDATE 2-Data supports Novartis malaria drug -US FDA staff Reuters - Novartis ' data also showed Coartem, which is given twice daily for three days, appears "superior" to treatments using the drug's individual ingredients, ... Novartis Malaria Drug Gets Favorable US FDA Review (Update3) FDA: Novartis malaria pill shows superior results Data supports Novartis malaria drug -US FDA staff
02 Dec 2008 14:44:23

Mylan settles with Novartis over its breat-cancer drug - MarketWatch

Mylan settles with Novartis over its breat-cancer drug MarketWatch - Under the agreement, the generic form of Novartis ' breast-cancer treatment will be licensed for marketing, Pittsburgh-based Mylan said. ...
02 Dec 2008 14:32:06

Cerimon Pharmaceuticals Appoints James S. Shannon, MD, to Board of ... - SYS-CON Brasil

Cerimon Pharmaceuticals Appoints James S. Shannon, MD, to Board of ... SYS-CON Brasil, NJ - He spearheaded the integration of R&D programs during Sandoz' merger with Ciba-Geigy, creating the renowned Novartis pipeline. ...
01 Dec 2008 19:50:53

UPDATE 1-Novartis expects Afinitor approval in Q1 - guardian.co.uk

UPDATE 1- Novartis expects Afinitor approval in Q1 guardian.co.uk, UK - By Paul Arnold ZURICH, Dec 1 (Reuters) - Novartis is on track to win regulatory approval for its cancer drug Afinitor in the first quarter of 2009, ...
01 Dec 2008 15:47:57

Wachovia Upgrades Alcon (ACL) to Outperform, Strong Chance Company ... - StreetInsider.com (subscription)

Wachovia Upgrades Alcon (ACL) to Outperform, Strong Chance Company ... StreetInsider.com (subscription), MI - We think Novartis (NYSE: NVS) will ultimately acquire ACL. On April 7, 2008, Novartis and Nestle announced an agreement whereby Nestle would sell a 25% ...
01 Dec 2008 10:42:39

Woman sues drug company Novartis - Quad City Times

Woman sues drug company Novartis Quad City Times, IA - She filed the lawsuit on behalf of herself and her son against Novartis in US District Court, Davenport. Marolf took the drug Zelnorm from 2002 through 2007 ...
01 Dec 2008 07:00:26

Scrutiny Grows of Drug Trials Abroad - Wall Street Journal

Scrutiny Grows of Drug Trials Abroad Wall Street Journal - Last year, two elderly patients died after Polish investigators enrolled them in a study of a bird-flu vaccine being developed by Novartis AG even though ... Overseas Clinical Trials Are Under the Microscope Overseas regulators toughens clinical trial stance
26 Nov 2008 08:44:12

Novartis CEO sees pressure on drug sector - report - Reuters

Calgary Herald Novartis CEO sees pressure on drug sector - report Reuters - But we will be under added pressure from the cooling economy, anyhow," Novartis Chief Executive Daniel Vasella told Handelszeitung. ... Europe stocks rise as buoyant pharmas offset miners

Keywords:

ALL NEWS TODAY © PoznaiSebya.Сom
Designer Dmytriev Dmytriy